What is risk?
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7036 (Published 23 October 2012) Cite this as: BMJ 2012;345:e7036- Philip Sedgwick, reader in medical statistics and medical education
- 1Centre for Medical and Healthcare Education, St George’s, University of London, Tooting, London, UK
- p.sedgwick{at}sgul.ac.uk
Titrated oxygen was compared with the standard treatment of high flow oxygen for patients with acute exacerbation of chronic obstructive pulmonary disease in the pre-hospital setting. A cluster, randomised controlled, parallel group trial was performed. In total, 405 patients with a presumed acute exacerbation of chronic obstructive pulmonary disease that had been treated by paramedics and who had been transported and admitted to hospital were included. A total of 226 patients were randomised to high flow oxygen and 179 to titrated oxygen. The main outcome measure was mortality, either pre-hospital or in-hospital mortality.1
The risk of mortality in patients randomised to titrated oxygen treatment was less than that in the patients randomised to high flow oxygen (seven deaths (3.9% of patients) versus 21 deaths (9.3%)). The researchers concluded that titrated oxygen treatment significantly reduced mortality in comparison with high flow oxygen in acute exacerbations of chronic obstructive pulmonary disease (relative risk 0.42 (95% confidence interval 0.2 to 0.89; P=0.02)).
Which of the following statements, if any, are true?
a) The …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.